Although methylated markers such as RASSF1A, SDC2, BCAT1, IKZF1, ALX4, SDC2 and WIF-1, among others, have demonstrated some usefulness for the detection of established cancers [17,21,22], the goal of detecting precancerous adenomas has not been achieved yet. This evidence concerns the gene SDC2 and cancer.